Rasmus Gantzel

Medical doctor and PhD fellow at @hepgas, Aarhus University Hospital.
Research area: Hepatology - cirrhosis

[Rasmus Gantzel @RGantzel]

Thrilling new results revealing a reduced burden of viral #hepatitis in #Greenland: "Viral Hepatitis B, C and Delta in Greenland: A National Cross‐Sectional Study". Dig into the exciting data; https://t.co/bFuYMSejqC
@HepGas @wileyinresearch

[Rasmus Gantzel @RGantzel]

Thrilled to share that our PRO based CIRAS model also predicts hepatic hydrothorax. A refreshing approach enhancing personalized care and risk stratification for patients with #cirrhosis and ascites. #Hepatology #PRO @HepGas
Link: https://t.co/9aILacs2XG

[Rasmus Gantzel @RGantzel]

Excited to share our research results on natriuretic peptide ularitide for refractory cirrhotic ascites. While the results showed safety challenges, each study brings us closer to better treatments. Thanks, @ebtapper, for highlighting this!
Link: https://t.co/9jkBelv05F
@HepGas

[Elliot Tapper @ebtapper]

Brilliant idea that didn’t pan out

https://t.co/SDZTqqJOfS

Natriuretic peptide neither effectiver no safe for ascites

@HGronbaek @HepatoEpi @HepGas in @HepCommJournal

[Rasmus Gantzel @RGantzel]

New insights in autoimmune liver diseases! Greenland's prevalence stands at 24 per 100,000 — remarkably lower than Scandinavia and Alaska Inuit. Dive into the ice-breaking study here: https://t.co/lVJvacr897. #LiverHealth #AutoimmuneResearch @HepGas @RGantzel @HGronbaek

[Elliot Tapper @ebtapper]

A randomized trial of statins for #cirrhosis!

Many talk about it, these authors did it. #Livertwitter is indebted to them and their patients

Thrilled to see this out in @HepCommJournal

https://t.co/Sta8F906fL

[Rasmus Gantzel @RGantzel]

Indigenous Arctic people may face a similar risk of #NAFLD as the global population. @HepGas and Steno Greenland conducted this systematic review calling for further research in metabolic liver diseases in these populations. #ArcticHealth #IndigenousHealth
https://t.co/JtG9Rbxq1A

[Rasmus Gantzel @RGantzel]

"Did you know #IBD affects Arctic populations too?
This new nationwide study from Greenland finds a 0.45% prevalence of IBD with similar rates across regions. Learn more about UC and CD in #Greenland: https://t.co/PG9HuU9TTe
@HepGas @HGronbaek @IBDJournals

[Rasmus Gantzel @RGantzel]

Excited about this new #CochraneReview protocol investigating prognostic models to predict colorectal cancer incidence or mortality in patients with #IBD.
@HepGas @LiseHelsingen #ISCAN @cochranecollab
Check it out --> https://t.co/bV7wCaTYjb

[Rasmus Gantzel @RGantzel]

Great day at #NUNAMED presenting results on #MAFLD in Greenland.

[Hepatology Communications @HepCommJournal]

📑CIRAS is a simple patient-centered model that describes the severity of #ascites and predicts one-year mortality!
1️⃣Patient-reported ascites discomfort
2️⃣Plasma Sodium
3️⃣Composite of ascites accumulation and diuretic treatment. 
https://t.co/KxpBOZO5C1
#LiverTwitter #OpenAccess

[Rasmus Gantzel @RGantzel]

Preliminary results were presented at #ilc2021 - we are now looking forward to disseminate the final results to our peers @EASLnews

[Rasmus Gantzel @RGantzel]

Natriuretic peptides induce natriuresis and diuresis in patients with cirrhotic ascites!
- We have systematically reviewed the effects and safety.
- Check it out -> https://t.co/TPnZ0Z6bGf
@HepGas @mikkelkjaer3 @HGronbaek

[Rasmus Gantzel @RGantzel]

We are excited to present the results at #ilc2022 @EASLnews.

[Rasmus Gantzel @RGantzel]

Are Greenlanders protected against non-alcoholic fatty liver disease?
In this register-based cross-sectional study, we found that Greenlanders with T2DM had elevated ALAT but lower FIB4 score than Danes in Greenland: https://t.co/URk6YJRIbd.
@HepGas @HGronbaek @GerdaElisabeth